FDA Approved: RAYALDEE — Original Application (OPKO Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved RAYALDEE (calcifediol) from OPKO Pharmaceuticals as a new drug for adults with stage 3–4 chronic kidney disease and hypocalcemia due to seconda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism
• Hypocalcemia

Drugs mentioned

• Rayaldee (calcifediol)

Snippet

ORIG AP for RAYALDEE (CALCIFEDIOL)